This paper provides a comprehensive review of Interferons (IFNs), a class of signaling proteins crucial in health and disease. It details the three main types of IFNs (I, II, and III), highlighting their structural and functional differences, despite all signaling through Janus kinases. The review covers the cellular and molecular mechanisms of IFN induction and response, including the roles of pattern-recognition receptors (PRRs) and the subsequent activation of the JAK/STAT signaling pathway to produce interferon-stimulated genes (ISGs). Furthermore, the document extensively explores the pleiotropic and sometimes opposing roles of IFNs in various pathological contexts, such as viral and bacterial infections, inflammatory and autoimmune diseases (including interferonopathies), and conditions affecting mucosal surfaces like the respiratory and gastrointestinal tracts.

References:

• Boehmer D, Zanoni I. Interferons in health and disease[J]. Cell, 2025, 188(17): 4480-4504.

This article in Nature, details the concept that a breakdown in the endosymbiotic relationship between mitochondria and the host cell may be a foundational cause of inflammatory and autoimmune diseases. Mitochondria, retaining traits from their bacterial origin, can release various factors—including proteins, nucleic acids (mtDNA/mtRNA), metabolites, and reactive oxygen species (ROS)—into the cytosol when their protective outer membrane is breached. The text explains that the cell can recognize these mitochondrial factors as "foreign" or danger signals, triggering innate immune responses like inflammation and cell death pathways, often mirroring the mechanisms used to detect bacterial or viral pathogens. The authors hypothesize that modern environmental factors like obesity, dietary changes, and chronic stress may drive this mitochondrial dysfunction and subsequent inflammatory signaling, suggesting new avenues for therapeutic intervention.

References:

• Murphy M P, O’Neill L A J. A break in mitochondrial endosymbiosis as a basis for inflammatory diseases[J]. Nature, 2024, 626(7998): 271-279.

This review focus on Natural Killer (NK) cell therapies, specifically exploring their potential for cancer treatment. It comprehensively details the biology and function of NK cells, including their classification into subsets and their unique ability to recognize and eliminate distressed cells, such as tumor cells, without requiring prior antigen-specific priming like T cells. The source analyzes current and emerging therapeutic strategies centered on harnessing NK cell immunity, which include monoclonal-antibody-based therapies like immune checkpoint inhibitors and NK cell engagers, and cell-based therapies such as infusions of ex vivo conditioned or genetically modified NK cells, including CAR NK cells. Finally, the text discusses the challenges and future directions for optimizing NK cell efficacy, such as enhancing persistence and developing effective combination treatments, especially for solid tumors.

References:

• Vivier E, Rebuffet L, Narni-Mancinelli E, et al. Natural killer cell therapies[J]. Nature, 2024, 626(8000): 727-736.

This research article introducing the Cell Marker Accordion, a new computational platform designed to improve the interpretation and automatic annotation of single-cell and spatial omics data in both healthy and diseased tissues. The authors highlight that existing tools suffer from inconsistent marker sets and poor interpretability, especially when identifying disease-critical cell populations. The Cell Marker Accordion addresses this by integrating multiple marker gene databases, standardizing nomenclature, and weighting markers based on both their specificity and evidence consistency across sources. Validation studies show that the platform improves annotation accuracy and is faster than previous marker-based tools, demonstrating its utility in identifying aberrant cell types in various pathologies, including acute myeloid leukemia and solid tumors.

References:

• Busarello E, Biancon G, Cimignolo I, et al. Cell Marker Accordion: interpretable single-cell and spatial omics annotation in health and disease[J]. Nature Communications, 2025, 16(1): 5399.

The review article titled "The integrative biology of type 2 diabetes," summarizes recent research on the pathogenesis of type 2 diabetes (T2D), a rapidly increasing global health concern. The authors, Michael Roden and Gerald I. Shulman, focus on understanding insulin resistance and increased hepatic gluconeogenesis associated with obesity and T2D, drawing heavily on studies in humans and animal models. A core concept presented is a unifying model where adipose tissue dysfunction and the resulting increased lipolysis lead to ectopic lipid deposition in the liver and muscle, driving insulin resistance and hyperglycemia by altering metabolic fluxes. The review also discusses the role of genetics, lifestyle factors, and the brain in regulating metabolism, ultimately providing an outlook on future precision medicine approaches for T2D treatment.

References:

• Roden M, Shulman G I. The integrative biology of type 2 diabetes[J]. Nature, 2019, 576(7785): 51-60.

This article addresses the multifaceted problem of drug resistance in cancer therapy. The authors articulate a framework for understanding resistance by defining its key biological determinants, including tumor burden and growth kinetics, heterogeneity, physical barriers, the immune system, and undruggable genomic drivers. They propose four general solutions to overcome resistance: earlier detection of tumors, achieving deeper therapeutic responses, continuous monitoring and adaptive interventions during therapy, and mapping cancer cell dependencies. The article emphasizes that drug resistance is the primary obstacle to curing cancer and suggests that integrating new technological and pharmacological approaches offers a pathway to more effective, individualized treatment strategies.

References:

• Vasan N, Baselga J, Hyman D M. A view on drug resistance in cancer[J]. Nature, 2019, 575(7782): 299-309.

This paper details research into the mechanisms governing cellular plasticity in thymic epithelial cells (mTECs), which is essential for immune tolerance. The authors demonstrate that fluctuations in background chromatin accessibility, termed "epigenetic noise," are amplified during mTEC maturation and promote the ectopic expression of genes normally restricted to other cell types. Crucially, this epigenetic noise is associated with the repression of the tumor suppressor p53; conversely, augmenting p53 activity stabilizes chromatin, suppresses ectopic gene expression, and restricts cellular plasticity, leading to multi-organ autoimmunity in mice. The study also links this noise to genomically encoded AT-rich sequences and suggests a similar regulatory role for p53 in suppressing plasticity during lung adenocarcinoma progression.

References:

• Gamble N, Caldwell J A, McKeever J, et al. Thymic epithelial cells amplify epigenetic noise to promote immune tolerance[J]. Nature, 2025: 1-10.

This paper presents an in-depth review of how various advanced technologies are being integrated to revolutionize crop improvement and address global food security challenges. It examines the synergistic application of four key areas: Omics technologies (including genomics and metabolomics) for generating vast datasets and understanding plant biology; Genome editing for precise genetic modifications; Protein design for creating novel traits; and High-throughput phenotyping (HTP) for rapidly evaluating genetic variants. The authors emphasize the emerging role of Artificial Intelligence (AI) in enhancing these technologies, accelerating the selection and incorporation of elite alleles into existing or newly domesticated crops, and ultimately proposing a framework for AI-aided crop design. This integration, they argue, is crucial for developing sustainable and resilient crops capable of meeting the demands of a growing population facing climate change and limited resources.

References:

• Li G, An L, Yang W, et al. Integrated biotechnological and AI innovations for crop improvement[J]. Nature, 2025, 643(8073): 925-937.

This paper consist of two distinct previews from the journal Cancer Cell, each focusing on recent scientific investigations related to cancer. The first source, "Tumor neutrophils rewired from birth," summarizes research indicating that tumor-derived signals systemically reprogram neutrophil development in the bone marrow, leading to immunosuppressive imprinting, but notes that IL-1β blockade can reverse this pathology and limit metastatic spread. The second source, "Drug-induced mismatch repair deficiency: Mixed prospects," discusses studies showing that chemotherapy combinations can induce mismatch repair-deficient-like phenotypes in typically mismatch repair-proficient colorectal cancers, potentially converting them into tumors more responsive to immune checkpoint inhibitors, though clinical efficacy remains uncertain. Both pieces examine new strategies for modulating the tumor microenvironment and systemic immune responses to improve cancer treatment.

References:

• Dong L, Ng L G. Tumor neutrophils rewired from birth[J]. Cancer Cell, 2025.

This excerpt from a scientific article details a study investigating how mechanical confinement in the tumor microenvironment drives phenotype switching in melanoma cells from a proliferative to an invasive and drug-resistant state. Using models including zebrafish melanoma and human cell lines, the researchers demonstrate that physical pressure causes melanoma cells to adopt an undifferentiated, neuronal-like identity. This process is mediated by the DNA-bending protein HMGB2, which is upregulated by confinement via a mechanism involving the LINC complex protein nesprin 2 and a stabilizing perinuclear acetylated tubulin cage. The resulting increase in HMGB2 stabilizes its interactions with chromatin, thereby increasing accessibility at loci associated with a neuronal and invasive phenotype, ultimately linking mechanical stress to melanoma progression and therapeutic resistance.

References:

• Hunter M V, Joshi E, Bowker S, et al. Mechanical confinement governs phenotypic plasticity in melanoma[J]. Nature, 2025: 1-11.